Canntab Therapeutics ahs developed a product line of solid oral dose delivery systems including extended release (XR), flash melt, immediate release, modified release and bi-layered tablet solutions that provide a variety of cannabinoid and terpenoid blends in exacting dosages.

Pharmaceutical

Canntab Therapeutics

Jeff Renwick

Robert Lefler

Larry Latowsky

Richard Goldstein

Tommy Larocque

Eric Malinski

The current leadership team at Canntab Therapeutics has a wealth of experience in the biotech and pharmaceutical industries. The team includes the former Chief Scientific Officer at Berkeley BioPharma, the Managing Director at CMAX Technologies Inc., and the Director at Alliance Grain Traders. The team also has experience in other industries, with the President coming from Standard Biochem Inc. All members of the team have extensive experience in their respective fields and will no doubt be able to lead Canntab Therapeutics to success.

Leadership Team

Board of Directors

CEO and Executive Team

Leadership Team

About

Team members

Other teams at Canntab Therapeutics

Board of Directors

CEO and Executive Team